Table 3

Staining results of evaluable cores (%)

CALD

CD9

CD99

FABP3

SERPINA1

TRPS1

VIM


Clear cell RCC

No stain

235/235

(100.0)

215/229

(93.9)

187/213

(87.8)

137/232

(59.1)

105/217

(48.4)

208/212

(98.1)

134/220

(60.9)

Weak

0/235

(0.0)

10/229

(4.4)

21/213

(9.9)

53/232

(22.8)

63/217

(29.0)

2/212

(0.9)

28/220

(12.7)

Strong

0/235

(0.0)

4/229

(1.7)

5/213

(2.3)

42/232

(18.1)

49/217

(22.6)

2/212

(0.9)

58/220

(26.4)


Chomophobe RCC

No stain

24/24

(100.0)

0/24

(0.0)

13/23

(56.5)

13/24

(54.2)

1/22

(4.5)

6/22

(27.3)

24/24

(100.0)

Weak

0/24

(0.0)

2/24

(8.3)

7/23

(30.4)

5/24

(20.8)

7/22

(31.8)

11/22

(50.0)

0/24

(0.0)

Strong

0/24

(0.0)

22/24

(91.7)

3/23

(13.0)

6/24

(25.0)

14/22

(63.6)

5/22

(22.7)

0/24

(0.0)


Papillary RCC

No stain

37/37

(100.0)

36/36

(100.0)

20/32

(62.5)

17/36

(47.2)

20/34

(58.8)

31/31

(100.0)

16/34

(47.1)

Weak

0/37

(0.0)

0/36

(0.0)

7/32

(21.9)

9/36

(25.0)

10/34

(29.4)

0/31

(0.0)

10/34

(29.4)

Strong

0/37

(0.0)

0/36

(0.0)

5/32

(15.6)

10/36

(27.8)

4/34

(11.8)

0/31

(0.0)

8/34

(23.5)


Unclassified RCC

No stain

13/13

(100.0)

10/13

(76.9)

4/9

(44.4)

7/13

(53.8)

6/11

(54.5)

10/11

(90.9)

4/12

(33.3)

Weak

0/13

(0.0)

1/13

(7.7)

3/9

(33.3)

3/13

(23.1)

4/11

(36.4)

1/11

(9.1)

2/12

(16.7)

Strong

0/13

(0.0)

2/13

(15.4)

2/9

(22.2)

3/13

(23.1)

1/11

(9.1)

0/11

(0.0)

6/12

(50.0)


Urothelial carcinoma

No stain

45/45

(100.0)

46/46

(100.0)

38/43

(88.4)

29/46

(63.0)

23/47

(48.9)

38/44

(86.4)

40/43

(93.0)

Weak

0/45

(0.0)

0/46

(0.0)

4/43

(9.3)

12/46

(26.1)

19/47

(40.4)

5/44

(11.4)

1/43

(2.3)

Strong

0/45

(0.0)

0/46

(0.0)

1/43

(2.3)

5/46

(10.9)

5/47

(10.6)

1/44

(2.3)

2/43

(4.7)


Oncocytoma

No stain

16/16

(100.0)

7/16

(43.8)

1/13

(7.7)

3/16

(18.75)

13/16

(81.3)

9/15

(60.0)

16/16

(100.0)

Weak

0/16

(0.0)

6/16

(37.5)

2/13

(15.4)

6/16

(37.5)

2/16

(12.5)

4/15

(26.7)

0/16

(0.0)

Strong

0/16

(0.0)

3/16

(18.8)

10/13

(76.9)

7/16

(43.8)

1/16

(6.3)

2/15

(13.3)

0/16

(0.0)


Angiomyolipoma

No stain

1/11

(9.1)

10/10

(100.0)

5/10

(50.0)

7/10

(70.0)

3/11

(27.3)

7/12

(58.3)

6/8

(75.0)

Weak

0/11

(0.0)

0/10

(0.0)

5/10

(50.0)

3/10

(30.0)

5/11

(45.5)

5/12

(41.7)

1/8

(12.5)

Strong

10/11

(90.9)

0/10

(0.0)

0/10

(0.0)

0/10

(0.0)

3/11

(27.3)

0/12

(0.0)

1/8

(12.5)


Williams et al. BMC Clinical Pathology 2009 9:9   doi:10.1186/1472-6890-9-9

Open Data